NCT06767982View on ClinicalTrials.gov

Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Non Muscle Invasive Bladder Cancer

Interventions

DRUG

Bacillus Calmette-Guerin (BCG)

In this study we compared the efficacy and side effects of two different strains of BCG (RIVM and RUSSIAN strains) in non muscle invasive bladder cancer patients

Trial Locations (1)

Unknown

Ankara University Faculty of Medicine Ibni Sina Hospital, Ankara

All Listed Sponsors

lead

Ankara University

OTHER

NCT06767982 - Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC) | Biotech Hunter | Biotech Hunter